Schedule 13G ownership disclosure

ELEDON PHARMACEUTICALS INC COM

Common Stock · CUSIP: 28617K101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: 878,080.00 · Class: 1.5%

  • FHMLSP, L.P.

    Shares: 878,080.00 · Class: 1.5%

  • FHMLSP, L.L.C.

    Shares: 878,080.00 · Class: 1.5%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 258,998.00 · Class: 0.4%

  • FHMLSP Overage, L.P.

    Shares: 258,998.00 · Class: 0.4%

  • FHMLSP Overage, L.L.C.

    Shares: 258,998.00 · Class: 0.4%

  • Frazier Life Sciences X, L.P.

    Shares: 13,062.00 · Class: 0.0%

  • FHMLS X, L.P.

    Shares: 13,062.00 · Class: 0.0%

  • FHMLS X, L.L.C.

    Shares: 13,062.00 · Class: 0.0%

  • Frazier Life Sciences XI, L.P.

    Shares: 26,595.00 · Class: 0.0%

  • FHMLS XI, L.P.

    Shares: 26,595.00 · Class: 0.0%

  • FHMLS XI, L.L.C.

    Shares: 26,595.00 · Class: 0.0%

  • James N. Topper

    Shares: 1,176,735.00 · Class: 2.0%

  • Patrick J. Heron

    Shares: 1,176,735.00 · Class: 2.0%

  • Albert Cha

    Shares: 1,137,078.00 · Class: 1.9%

  • James Brush

    Shares: 1,137,078.00 · Class: 1.9%

  • Daniel Estes

    Shares: 26,595.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-003986
Form type
SCHEDULE 13G/A
Filer
Eledon Pharmaceuticals, Inc.
CIK
CIK 1404281
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub